Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF – Autorité des Marchés Financiers)
Press release
Avignon, October 7th, 2011
30.09.2011
Total number of outstanding shares forming the capital
|
6,421,740 |
Total number of outstanding shares forming the capital
|
5,034,432 |
Number of shares with double voting rights |
86,641 |
Total number of gross voting rights |
5,121,073 |
Number of shares without voting rights
|
- 2,430 |
Total number of exercisable voting rights* |
5,108,853 |
*Real number of voting rights = total number of voting rights – number of shares without voting rights
If you would like to receive FINANCIAL information about Naturex by e-mail, go to: www.naturex.fr
Naturex has been listed since October 1996 on NYSE Euronext in Paris, compartment B
Number of shares comprising the capital: 6,421,740
Naturex is eligible for "long only" Deferred Settlement Service (SRD). MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX: FP |
About Naturex
Naturex is the world leader in specialty plant-based ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care -, produces and markets specialty plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetics industries.
Naturex's head office is based in Avignon. Naturex employs 950 people and has high-performance industrial resources across its 11 industrial sites in Europe (France, Italy, Spain, United Kingdom and Switzerland), in Morocco, the United States, Brazil and Australia. The company draws on its worldwide sales presence through a fully dedicated sales network in 19 countries (France, Italy, Spain, United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, United States, Canada, Brazil and Mexico).
• Contacts | |
Jacques Dikansky President and Chief Executive Officer Tel.: +33 (0)4 90 23 96 89 naturex@naturex.com |
Thierry Lambert Vice-President Tel.: +33 (0)4 90 23 96 89 t.lambert@naturex.com |
Carole Alexandre Investor Relations Tel.: +33 (0)4 90 23 78 28 c.alexandre@naturex.com |
Anne Catherine Bonjour Actus Finance Press Relations Tel.: +33 (0)1 53 67 36 93 acbonjour@actus.fr |